Event Details

Initial Preliminary Data from Phase 1 SWORD-1 Study of TPX-0046

Apr 05, 2021 at 4:30 PM EDT

Terms of Use | Copyright © 2021 Turning Point Therapeutics, Inc. | All Rights Reserved